Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8700
-0.2800 (-24.35%)
At close: Oct 7, 2026, 4:00 PM
0.9300
+0.0600 (6.90%)
After-hours: Oct 7, 2026, 7:49 PM EDT
Kairos Pharma Employees
As of December 31, 2025, Kairos Pharma had 4 total employees, including 1 full-time and 3 part-time employees. The number of employees did not change compared to the previous year. That makes Kairos Pharma the world's 42,065th largest employer and 6,653rd in the United States.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,451,250
Market Cap
2.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 1 | 3 |
| Dec 31, 2024 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Lexaria Bioscience | 7 |
| Creative Medical Technology Holdings | 4 |
| 60 Degrees Pharmaceuticals | 3 |
KAPA News
- 1 day ago - Kairos Pharma announces interim efficacy data from Phase 2 trial of ENV-105 - TheFly
- 1 day ago - Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer - Business Wire
- 14 days ago - Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA - Business Wire
- 23 days ago - Kairos Pharma Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 23 days ago - Kairos Pharma Slides: Investor presentation - Filings
- 4 weeks ago - Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 6 weeks ago - Kairos Pharma announces 1-for-7 reverse stock split - TheFly
- 6 weeks ago - Kairos Pharma Announces 1-for-7 Reverse Stock Split - Business Wire